The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
HIV infection
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationMicrobial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,798
Gottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Self-citationAuvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R., & Puren, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020298 · Cited by 2,451
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
Bailey, R. C., Moses, S., Parker, C. B., Agot, K., Maclean, I., Krieger, J. N., Williams, C. F., Campbell, R. T., & Ndinya-Achola, J. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60312-2 · Cited by 2,292
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray, R. H., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N., Moulton, L. H., Chaudhary, M. A., Chen, M. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60313-4 · Cited by 2,226
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
Self-citationQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,885
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Müßig, A., Allers, K., Schneider, T., Hofmann, J., Kücherer, C., Blau, O., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802905 · Cited by 1,837
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Mallal, S., Phillips, E., Carosi, G., Molina, J.-M., Workman, C., Tomažič, J., Jägel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706135 · Cited by 1,835
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Preexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
Violari, A., Cotton, M. F., Gibb, D. M., Babiker, A. G., Steyn, J., Madhi, S. A., Jean-Philippe, P., & McIntyre, J. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800971 · Cited by 1,418
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
HIV Infection and the Risk of Acute Myocardial Infarction
Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Bidwell Goetz, M., Leaf, D., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,242
Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)
Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., et al. (1983) · Science · doi:10.1126/science.6601823 · Cited by 1,238
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
Jewkes, R. K., Dunkle, K., Nduna, M., & Shai, N. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60548-x · Cited by 1,215
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
South African National HIV Prevalence, Incidence and Behaviour Survey, 2012
Shisana, O., Rehle, T. M., Simbayi, L. C., Zuma, K. K., Jooste, S. E., Zungu, N. P., Labadarios, D., & Onoya, D. (2014) · Cited by 1,190
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Study, T. I. H. C. (2010) · Science · doi:10.1126/science.1195271 · Cited by 1,171
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Marks, G., Crepaz, N., & Janssen, R. S. (2006) · AIDS · doi:10.1097/01.aids.0000233579.79714.8d · Cited by 1,096
Schwartz, O., Maréchal, V., Gall, S. L., Lemonnier, F., & Heard, J.-M. (1996) · Nature Medicine · doi:10.1038/nm0396-338 · Cited by 1,060
Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapía, M., Montoya-Herrera, O., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004006 · Cited by 1,020
Self-citationSáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Hansen, S. G., Ford, J. C., Lewis, M. S., Ventura, A. B., Hughes, C. M., Coyne-Johnson, L., Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011) · Nature · doi:10.1038/nature10003 · Cited by 988
Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1
Keele, B. F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M. L., Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegeois, F., et al. (2006) · Science · doi:10.1126/science.1126531 · Cited by 957
Shankarappa, R., Margolick, J. B., Gange, S. J., Rodrigo, A. G., Upchurch, D., Farzadegan, H., Gupta, P., Rinaldo, C. R., Learn, G. H., He, X., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10489-10502.1999 · Cited by 926
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Walmsley, S. L., Antela, A., Clumeck, N., Duiculescu, D., Eberhard, A., Gutiérrez, F., Hocqueloux, L., Maggiolo, F., Sandkovsky, U., Granier, C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215541 · Cited by 876
Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 + T Cells
Zhang, Z.-Q., Schuler, T., Zupancic, M., Wietgrefe, S., Staskus, K. A., Reimann, K. A., Reinhart, T. A., Rogan, M., Cavert, W., Miller, C. J., et al. (1999) · Science · doi:10.1126/science.286.5443.1353 · Cited by 874
Systemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 868
Self-citationDavey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
Chun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
Deeks, S. G., Kitchen, C. M. R., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P., Martin, J. N., Kahn, J. O., Levy, J., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 804
Self-citationPatient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review
Rosen, S., Fox, M. P., & Gill, C. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040298 · Cited by 796
Deeks, S. G., & Walker, B. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.010 · Cited by 759
Self-citationInnate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2035 · Cited by 750
Self-citationEstimating per-act HIV transmission risk: a systematic review
Patel, P., Borkowf, C. B., Brooks, J. T., Lasry, A., Lansky, A., & Mermin, J. (2014) · AIDS · doi:10.1097/qad.0000000000000298 · Cited by 748
Stacey, A. R., Norris, P. J., Qin, L., Haygreen, E. A., Taylor, E., Heitman, J., Lebedeva, M., DeCamp, A., Li, D., Grove, D., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01844-08 · Cited by 747
Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review
Rosen, S., & Fox, M. P. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001056 · Cited by 738
The early spread and epidemic ignition of HIV-1 in human populations
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., et al. (2014) · Science · doi:10.1126/science.1256739 · Cited by 736
Spira, A. I., Marx, P. A., Patterson, B. K., Mahoney, J., Koup, R. A., Wolinsky, S. M., & Ho, D. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.215 · Cited by 692
Weiss, H. A., Quigley, M. A., & Hayes, R. J. (2000) · AIDS · doi:10.1097/00002030-200010200-00018 · Cited by 671
Guidelines for the use of antiretroviral agents in pediatric HIV infection: (477722008-001)
(2008) · PsycEXTRA Dataset · doi:10.1037/e477722008-001 · Cited by 670
Fletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
Deeks, S. G., Wrin, T., Liegler, T., Hoh, R., Hayden, M., Barbour, J. D., Hellmann, N. S., Petropoulos, C. J., McCune, J. M., Hellerstein, M. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440702 · Cited by 653
Self-citationHIV-1 Transmission, by Stage of Infection
Hollingsworth, T. D., Anderson, R. M., & Fraser, C. (2008) · The Journal of Infectious Diseases · doi:10.1086/590501 · Cited by 652
Worm, S. W., Sabin, C., Weber, R., Reiss, P., El‐Sadr, W., Dabis, F., De Wit, S., Law, M., Monforte, A. D., Friis‐Møller, N., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 648
Self-citationIn vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
Scarlatti, G., Tresoldi, E., Björndal, Å., Fredriksson, R., Colognesi, C., Kui Deng, H., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., et al. (1997) · Nature Medicine · doi:10.1038/nm1197-1259 · Cited by 633
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
Whitney, J. B., Hill, A. L., Sanisetty, S., Penaloza-MacMaster, P., Liu, J., Shetty, M., Parenteau, L., Cabral, C., Shields, J., Blackmore, S., et al. (2014) · Nature · doi:10.1038/nature13594 · Cited by 629
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
Self-citationImmune clearance of highly pathogenic SIV infection
Hansen, S. G., Jr, M. P., Ventura, A. B., Hughes, C. M., Gilbride, R. M., Ford, J. C., Oswald, K., Shoemaker, R., Li, Y., Lewis, M. S., et al. (2013) · Nature · doi:10.1038/nature12519 · Cited by 597
Migueles, S. A., Osborne, C. M., Royce, C., Compton, A. A., Joshi, R. P., Weeks, K. A., Rood, J. E., Berkley, A. M., Sacha, J. B., Cogliano-Shutta, N. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.10.010 · Cited by 590
The dynamics of CD4+ T-cell depletion in HIV disease
McCune, J. M. (2001) · Nature · doi:10.1038/35073648 · Cited by 583
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
HIV disease: fallout from a mucosal catastrophe?
Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579
Dendritic-cell interactions with HIV: infection and viral dissemination
Wu, L., & KewalRamani, V. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1960 · Cited by 574
Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenine
Tsai, C.-C., Follis, K. E., Sabo, A., Beck, T. W., Grant, R. F., Bischofberger, N., Benveniste, R. E., & Black, R. (1995) · Science · doi:10.1126/science.270.5239.1197 · Cited by 563
Fox, M. P., & Rosen, S. (2010) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2010.02508.x · Cited by 559
J Buzón, M., Massanella, M., Llibre, J. M., Esteve, A., Dahl, V., Puertas, M. C., Gatell, J. M., Domingo, P., Paredes, R., Sharkey, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2111 · Cited by 551
Tenorio, A. R., Zheng, Y., Bosch, R. J., Krishnan, S., Rodriguez, B., Hunt, P. W., Plants, J., Seth, A., Wilson, C. C., Deeks, S. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu254 · Cited by 546
Self-citationR??TTINGEN, J.-A., WILLIAM CAMERON, D., & GARNETT, G. P. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200110000-00005 · Cited by 540
Evolutionary and immunological implications of contemporary HIV-1 variation
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., & Detours, V. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.19 · Cited by 540
Favre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000632 · Cited by 523
Self-citationClotet, B., Feinberg, J., van Lunzen, J., Khuong-Josses, M.-A., Antinori, A., Dumitru, I., Pokrovskiy, V., Fehr, J., Ortiz, R., Saag, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60084-2 · Cited by 507
Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H. L., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 504
Self-citationGrinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Hunt, P. W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 478
Self-citationFukazawa, Y., Lum, R., Okoye, A. A., Park, H., Matsuda, K., Bae, J. Y., Hagen, S. I., Shoemaker, R., Deleage, C., Lucero, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3781 · Cited by 477
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Sandler, N. G., Bosinger, S. E., Estes, J. D., Zhu, R. T. R., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K. N., del Prete, G. Q., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 461
Günthard, H. F., Aberg, J. A., Eron, J. J., Hoy, J. F., Telenti, A., Benson, C. A., Burger, D. M., Cahn, P., Gallant, J. E., Glesby, M. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.8722 · Cited by 449
Perils at mucosal front lines for HIV and SIV and their hosts
Haase, A. T. (2005) · Nature Reviews Immunology · doi:10.1038/nri1706 · Cited by 440
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
Miller, C. J., Li, Q., Abel, K., Kim, E.-Y., Ma, Z.-M., Wietgrefe, S., La Franco-Scheuch, L., Compton, L., Duan, L., Shore, M. D., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9217-9227.2005 · Cited by 421
HIV-1 persistence in CD4+ T cells with stem cell–like properties
Buzon, M. J., Sun, H., Li, C., Shaw, A., Seiss, K., Ouyang, Z., Martin-Gayo, E., Leng, J., Henrich, T. J., Li, J. Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3445 · Cited by 414
Kelley, C. F., Kitchen, C. M. R., Hunt, P. W., Rodriguez, B., Hecht, F. M., Kitahata, M., Crane, H. M., Willig, J., Mugavero, M., Saag, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597093 · Cited by 407
Self-citation(2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70288-7 · Cited by 405
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt243 · Cited by 399
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/586713 · Cited by 399
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.
Bradley, H. M., Hall, H. I., Wolitski, R. J., Handel, M. M. V., Stone, A. E., LaFlam, M., Skarbinski, J., Higa, D. H., Prejean, J., Frazier, E. L., et al. (2014) · PubMed Central · Cited by 397
Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-1-201307020-00645 · Cited by 393
Antibody responses to envelope glycoproteins in HIV-1 infection
Burton, D. R., & Mascola, J. R. (2015) · Nature Immunology · doi:10.1038/ni.3158 · Cited by 385
HIV induces thymus depletion in vivo
Bonyhadi, M. L., Rabin, L., Salimi, S., Brown, D. A., Kosek, J., McCune, J. M., & Kaneshima, H. (1993) · Nature · doi:10.1038/363728a0 · Cited by 379
Raffi, F., Jaeger, H., Quiros-Roldan, E., Albrecht, H., Belonosova, E., Gatell, J. M., Baril, J.-G., Domingo, P., Brennan, C., Almond, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70257-3 · Cited by 379
Kuhar, D. T., Henderson, D. K., Struble, K. A., Heneine, W., Thomas, V., Cheever, L. W., Gomaa, A., Panlilio, A. L., & US Public Health Service Working Group (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/672271 · Cited by 377
Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
Severe, P., Jean Juste, M. A., Ambroise, A., Eliacin, L., Marchand, C., Apollon, S., Edwards, A., Bang, H., Nicotera, J., Godfrey, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910370 · Cited by 377
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
Baker, J. V., Peng, G., Rapkin, J., Abrams, D. I., Silverberg, M. J., MacArthur, R. D., Cavert, W. P., Henry, W. K., & Neaton, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3282f7cb76 · Cited by 372
Lyles, R. H., Muñoz, Á., Yamashita, T. E., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315339 · Cited by 362
Miners, A., Phillips, A., Kreif, N., Rodger, A., Speakman, A., Fisher, M., Anderson, J., Collins, S., Hart, G., Sherr, L., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70018-9 · Cited by 342
Self-citationThe increase in global HIV epidemics in MSM
Beyrer, C., Sullivan, P., Sanchez, J., Baral, S. D., Collins, C., Wirtz, A. L., Altman, D., Trapence, G., & Mayer, K. (2013) · AIDS · doi:10.1097/01.aids.0000432449.30239.fe · Cited by 341
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
West, A. P., Scharf, L., Scheid, J. F., Klein, F., Bjorkman, P. J., & Nussenzweig, M. C. (2014) · Cell · doi:10.1016/j.cell.2014.01.052 · Cited by 321
Child Mortality According to Maternal and Infant HIV Status in Zimbabwe
Marinda, E., Humphrey, J. H., Iliff, P. J., Mutasa, K., Nathoo, K. J., Piwoz, E. G., Moulton, L. H., Salama, P., & Ward, B. J. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000264527.69954.4c · Cited by 314
Bangsberg, D. R., Acosta, E. P., Gupta, R., Guzman, D., Riley, E. D., Harrigan, P. R., Parkin, N., & Deeks, S. G. (2006) · AIDS · doi:10.1097/01.aids.0000199825.34241.49 · Cited by 312
Self-citationCumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
Zeng, M., Smith, A. J., Wietgrefe, S. W., Southern, P. J., Schacker, T. W., Reilly, C. S., Estes, J. D., Burton, G. F., Silvestri, G., Lifson, J. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45157 · Cited by 309
Wawer, M. J., Makumbi, F., Kigozi, G., Serwadda, D., Watya, S., Nalugoda, F., Buwembo, D., Ssempijja, V., Kiwanuka, N., Moulton, L. H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60998-3 · Cited by 308
Fox, M. P., & Rosen, S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000553 · Cited by 306
Ryom, L., Mocroft, A., Kirk, O., Worm, S. W., Kamara, D. A., Reiss, P., Ross, M., Fux, C. A., Morlat, P., Moranne, O., et al. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit043 · Cited by 301
Self-citationLow CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study
Lichtenstein, K. A., Armon, C., Buchacz, K., Chmiel, J. S., Buckner, K., Tedaldi, E. M., Wood, K., Holmberg, S. D., & Brooks, J. T. (2010) · Clinical Infectious Diseases · doi:10.1086/655144 · Cited by 296
Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission
Baeten, J. M., Kahle, E., Lingappa, J. R., Coombs, R. W., Delany-Moretlwe, S., Nakku-Joloba, E., Mugo, N. R., Wald, A., Corey, L., Donnell, D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001888 · Cited by 293
Yukl, S. A., Boritz, E., Busch, M., Bentsen, C., Chun, T.-W., Douek, D., Eisele, E., Haase, A., Ho, Y.-C., Hütter, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003347 · Cited by 291
Self-citationThe role of HIV in serious diseases other than AIDS.
Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269
Self-citationLennox, J. L., Landovitz, R. J., Ribaudo, H. J., Ofotokun, I., Na, L. H., Godfrey, C., Kuritzkes, D. R., Sagar, M., Brown, T. T., Cohn, S. E., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-1084 · Cited by 262
Mocroft, A., Phillips, A., Gatell, J., Ledergerber, B., Fisher, M., Clumeck, N., Losso, M., Lazzarin, A., Fatkenheuer, G., & Lundgren, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60948-9 · Cited by 259
Self-citationGiorgi, J. V., Lyles, R. H., Matud, J. L., Yamashita, T. E., Mellors, J. W., Hultin, L. E., Jamieson, B. D., Margolick, J. B., Rinaldo, C. R., Phair, J. P., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204010-00004 · Cited by 246
Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective
Fraser, C., Lythgoe, K., Leventhal, G. E., Shirreff, G., Hollingsworth, T. D., Alizon, S., & Bonhoeffer, S. (2014) · Science · doi:10.1126/science.1243727 · Cited by 241
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
Ferre, A. L., Hunt, P. W., Critchfield, J. W., Young, D. H., Morris, M. M., Garcia, J. C., Pollard, R. B., Yee, H. F., Martin, J. N., Deeks, S. G., et al. (2009) · Blood · doi:10.1182/blood-2008-10-182709 · Cited by 237
Self-citationSmith, D. K., Herbst, J. H., Zhang, X., & Rose, C. E. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000461 · Cited by 236
Writing Group, Williams, I., Churchill, D., Anderson, J., Boffito, M., Bower, M., Cairns, G., Cwynarski, K., Edwards, S., Fidler, S., et al. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.01029.x · Cited by 226
Self-citationEmu, B., Sinclair, E., Hatano, H., Ferre, A., Shacklett, B., Martin, J. N., McCune, J. M., & Deeks, S. G. (2008) · Journal of Virology · doi:10.1128/jvi.02176-07 · Cited by 225
Self-citationGrowing Up with HIV: Children, Adolescents, and Young Adults with Perinatally Acquired HIV Infection
Hazra, R., Siberry, G. K., & Mofenson, L. M. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.050108.151127 · Cited by 224
Rhee, S.-Y., Blanco, J. L., Jordan, M. R., Taylor, J., Lemey, P., Varghese, V., Hamers, R. L., Bertagnolio, S., de Wit, T. F. R., Aghokeng, A. F., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001810 · Cited by 223
Mollan, K. R., Smurzynski, M., Eron, J. J., Daar, E. S., Campbell, T. B., Sax, P. E., Gulick, R. M., Na, L., O'Keefe, L., Robertson, K. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0293 · Cited by 211
Gray, R., Kigozi, G., Kong, X., Ssempiija, V., Makumbi, F., Wattya, S., Serwadda, D., Nalugoda, F., Sewenkambo, N. K., & Wawer, M. J. (2012) · AIDS · doi:10.1097/qad.0b013e3283504a3f · Cited by 209
Age, Comorbidities, and AIDS Predict a Frailty Phenotype in Men Who Have Sex With Men
Althoff, K. N., Jacobson, L. P., Cranston, R. D., Detels, R., Phair, J. P., Li, X., Margolick, J. B., & (MACS), F. T. M. A. C. S. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glt148 · Cited by 208
Paredes, R., Lalama, C. M., Ribaudo, H. J., Schackman, B. R., Shikuma, C., Giguel, F., Meyer, W. A., Johnson, V. A., Fiscus, S. A., D’Aquila, R. T., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650543 · Cited by 204
Selection Forces and Constraints on Retroviral Sequence Variation
Overbaugh, J., & Bangham, C. R. M. (2001) · Science · doi:10.1126/science.1059128 · Cited by 197
Self-citationRelative resistance of HIV-1 founder viruses to control by interferon-alpha
Fenton-May, A. E., Dibben, O., Emmerich, T., Ding, H., Pfafferott, K., Aasa-Chapman, M. M., Pellegrino, P., Williams, I., Cohen, M. S., Gao, F., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-146 · Cited by 197
Estes, J. D., Wietgrefe, S., Schacker, T., Southern, P., Beilman, G., Reilly, C., Milush, J. M., Lifson, J. D., Sodora, D. L., Carlis, J. V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/510852 · Cited by 193
Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients
Haukoos, J. S. (2010) · JAMA · doi:10.1001/jama.2010.953 · Cited by 187
Zeng, M., Southern, P. J., Reilly, C. S., Beilman, G. J., Chipman, J. G., Schacker, T. W., & Haase, A. T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002437 · Cited by 182
Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
Kimata, J. T., Kuller, L., Anderson, D. B., Dailey, P., & Overbaugh, J. (1999) · Nature Medicine · doi:10.1038/8414 · Cited by 175
Self-citationCD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21
Chen, H., Li, C., Huang, J., Cung, T., Seiss, K., Beamon, J., Carrington, M. F., Porter, L. C., Burke, P. S., Yang, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44539 · Cited by 175
Hatano, H., Strain, M. C., Scherzer, R., Bacchetti, P., Wentworth, D., Hoh, R., Martin, J. N., McCune, J. M., Neaton, J. D., Tracy, R. P., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit453 · Cited by 173
Self-citationSauce, D., Larsen, M., Fastenackels, S., Pauchard, M., Ait-Mohand, H., Schneider, L., Guihot, A., Boufassa, F., Zaunders, J., Iguertsira, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-331306 · Cited by 169
Self-citationGregson, S., Gonese, E., Hallett, T. B., Taruberekera, N., Hargrove, J. W., Lopman, B., Corbett, E. L., Dorrington, R., Dube, S., Dehne, K., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq055 · Cited by 167
Rockstroh, J. K., Lennox, J. L., DeJesus, E., Saag, M. S., Lazzarin, A., Wan, H., Walker, M. L., Xu, X., Zhao, J., Teppler, H., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir510 · Cited by 166
Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa
Hallett, T. B., Singh, K., Smith, J. A., White, R. G., Abu-Raddad, L. J., & Garnett, G. P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002212 · Cited by 163
Diffusion tensor spectroscopy (DTS) of human brain
Ellegood, J., Hanstock, C. C., & Beaulieu, C. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20777 · Cited by 161
New Paradigms for HIV/AIDS Vaccine Development
Picker, L. J., Hansen, S. G., & Lifson, J. D. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-042010-085643 · Cited by 160
UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000109 · Cited by 158
Gnanakaran, S., Tanmoy Bhattacharya, A., Daniels, M., Keele, B. F., Hraber, P., Lapedes, A. S., Shen, T., Gaschen, B. K., Krishnamoorthy, M., Li, H.-H., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002209 · Cited by 155
Frequency and implications of HIV superinfection
Redd, A. D., Quinn, T. C., & Tobian, A. A. R. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70066-5 · Cited by 153
Taiwo, B., Zheng, L., Gallien, S., Matining, R. M., Kuritzkes, D. R., Wilson, C. C., Berzins, B., Acosta, E. P., Bastow, B., Kim, P. S., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834bbaa9 · Cited by 149
Tellalian, D., Maznavi, K., Bredeek, U. F., & Hardy, W. D. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0173 · Cited by 145
Frailty in People Aging With Human Immunodeficiency Virus (HIV) Infection
Brothers, T. D., Kirkland, S., Guaraldi, G., Falutz, J., Theou, O., Johnston, B. L., & Rockwood, K. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu258 · Cited by 136
Polis, C. B., & Curtis, K. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70155-5 · Cited by 130
Miura, T., Brockman, M. A., Brumme, Z. L., Brumme, C. J., Pereyra, F., Piechocka‐Trocha, A., Block, B. L., Schneidewind, A., Allen, T. M., Heckerman, D. E., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01471-08 · Cited by 127
Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load
Alizon, S., von Wyl, V., Stadler, T., Kouyos, R. D., Yerly, S., Hirschel, B. J., Böni, J., Shah, C., Klimkait, T., Furrer, H., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001123 · Cited by 120
Association of HLA-DRB1–restricted CD4+ T cell responses with HIV immune control
Ranasinghe, S., Cutler, S., Davis, I., Lu, R., Soghoian, D. Z., Qi, Y., Sidney, J., Kranias, G., Flanders, M., Lindqvist, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3229 · Cited by 112
Self-citationChang, J. J., Woods, M., Lindsay, R. J., Doyle, E., Griesbeck, M., Chan, E. S., Robbins, G. K., Bosch, R. J., & Altfeld, M. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit262 · Cited by 111
Andrews, C. D., Yueh, Y. L., Spreen, W. R., Bernard, L. S., Boente-Carrera, M., Rodriguez, K., Gettie, A., Russell‐Lodrigue, K., Blanchard, J., Ford, S. L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010298 · Cited by 102
(2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 102
Sheppard, H. W., Celum, C., Michael, N. L., O’Brien, S. J., Dean, M. C., Carrington, M. N., Dondero, D. V., & Buchbinder, S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200203010-00013 · Cited by 101
Self-citationProspective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers
Hatano, H., Yukl, S. A., Ferre, A. L., Graf, E. H., Somsouk, M., Sinclair, E., Abdel‐Mohsen, M., Liegler, T. J., Harvill, K., Hoh, R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003691 · Cited by 101
Self-citationRichardson, B. A., Mbori‐Ngacha, D., Lavreys, L., John-Stewart, G. C., Nduati, R. W., Panteleeff, D., Emery, S., Kreiss, J. K., & Overbaugh, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7120-7123.2003 · Cited by 98
Self-citationExpression profile of host restriction factors in HIV-1 elite controllers
Abdel-Mohsen, M., Raposo, R. A. S., Deng, X., Li, M., Liegler, T., Sinclair, E., Salama, M. S., Ghanem, H. E.-D. A., Hoh, R., Wong, J. K., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-106 · Cited by 96
Self-citationPham, Q. D., Wilson, D. P., Law, M. G., Kelleher, A. D., & Zhang, L. (2014) · AIDS · doi:10.1097/qad.0000000000000494 · Cited by 95
The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection
Kelley, C. F., Barbour, J. D., & Hecht, F. M. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318074ef6e · Cited by 93
Bellan, S. E., Dushoff, J. G., Galvani, A. P., & Ancel, L. W. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001801 · Cited by 93
Sex-Based Outcomes of Darunavir–Ritonavir Therapy: A Single-Group Trial
Currier, J. S., Averitt, D., Hagins, D. P., Zorrilla, C., Feinberg, J., Ryan, R., Falcon, R., Tennenberg, A., Mrus, J. M., & Squires, K. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-6-201009210-00002 · Cited by 91
Novel vaccine vectors for HIV-1
Barouch, D. H., & Picker, L. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3360 · Cited by 90
Lelic, A., Verschoor, C. P., Ventresca, M., Parsons, R., Evelegh, C. M., Bowdish, D. M. E., Betts, M. R., Loeb, M. B., & Bramson, J. L. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003076 · Cited by 87
Okulicz, J. F., Le, T. D., Agan, B. K., Camargo, J. F., Landrum, M. L., Wright, E., Dolan, M. J., Ganesan, A., Ferguson, T. M., Smith, D. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4010 · Cited by 83
HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy
Mujugira, A., Celum, C., Coombs, R. W., Campbell, J. D., Ndase, P., Ronald, A., Were, E. O., Bukusi, E. A., Mugo, N., Kiarie, J. N., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001019 · Cited by 83
Kashuba, A. D. M., Gengiah, T. N., Werner, L., Yang, K., White, N., Karim, Q. A., & Karim, S. S. A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000607 · Cited by 79
2014 European Guideline on HIV testing
Gökengin, D., Geretti, A. M., Begovać, J., Palfreeman, A., Stevanovic, M., Тарасенко, О. М., & Radcliffe, K. W. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414531244 · Cited by 74
Soon, G. G., Min, M., Struble, K. A., Chan‐Tack, K. M., Hammerstrom, T., Qi, K., Zhou, S., Bhore, R., Murray, J. S., & Birnkrant, D. B. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0278 · Cited by 73
Caring for women living with HIV: gaps in the evidence
Loutfy, M. R., Sherr, L., Sonnenberg-Schwan, U., Walmsley, S. L., Johnson, M. A., Monforte, A. D., & Action, W. F. P. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.1.18509 · Cited by 71
Pilcher, C. D., Louie, B., Facente, S. N., Keating, S. M., Hackett, J., Vallari, A. S., Hall, C., Dowling, T., Busch, M. P., Klausner, J. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080629 · Cited by 71
HIV‐1 Transmission Biology: Selection and Characteristics of Infecting Viruses
Sagar, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/655656 · Cited by 71
HIV RNA level in early infection is predicted by viral load in the transmission source
Hecht, F. M., Hartogensis, W., Bragg, L., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328337b12e · Cited by 70
Role of F c‐mediated antibody function in protective immunity against HIV ‐1
Lewis, G. K. (2013) · Immunology · doi:10.1111/imm.12232 · Cited by 66
Cited by
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 382
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices
Li, P., Lee, G.-H., Kim, S. Y., Kwon, S. Y., Kim, H.-R., & Park, S. (2021) · ACS Nano · doi:10.1021/acsnano.0c06688 · Cited by 359
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S., Li, C., Kandimalla, M., Tang, X., Carmona Porquera, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 315
Metadata
- Authors
- Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-10-01
- Volume
- 1
- Issue
- 1
- Pages
- 15035-15035
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211183388
- Cited by
- 644
- References
- 214
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.